DVAX Logo

Dynavax Technologies Corporation (DVAX) 

NASDAQ
Market Cap
$1.62B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
519 of 774
Rank in Industry
29 of 47

Largest Insider Buys in Sector

DVAX Stock Price History Chart

DVAX Stock Performance

About Dynavax Technologies Corporation

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. …

Insider Activity of Dynavax Technologies Corporation

Over the last 12 months, insiders at Dynavax Technologies Corporation have bought $0 and sold $729,199 worth of Dynavax Technologies Corporation stock.

On average, over the past 5 years, insiders at Dynavax Technologies Corporation have bought $10M and sold $39.45M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000,000 shares for transaction amount of $10M was made by Hack Andrew A. F. (director) on 2020‑05‑27.

List of Insider Buy and Sell Transactions, Dynavax Technologies Corporation

2024-05-31Saledirector
3,615
0.0027%
$11.93$43,127-6.50%
2024-03-01SaleChief Accounting Officer
20,526
0.0157%
$12.78$262,322-10.26%
2024-01-04SaleSVP and CMO
1,500
0.0012%
$15.00$22,500-21.15%
2024-01-02SalePresident & COO
9,000
0.007%
$14.45$130,050-17.61%
2023-12-01SalePresident & COO
20,000
0.0153%
$13.56$271,200-12.82%
2023-11-03SalePresident & COO
20,000
0.0164%
$15.00$300,000-15.26%
2023-11-01SalePresident & COO
20,000
0.0155%
$14.12$282,400-14.54%
2023-10-10SaleSVP and CMO
1,755
0.0014%
$15.01$26,343-16.69%
2023-10-02SaleSVP and CMO
5,015
0.0039%
$15.03$75,375-17.56%
2023-10-02SalePresident & COO
40,000
0.0308%
$14.88$595,000-17.56%
2023-09-01SalePresident & COO
20,000
0.0155%
$14.48$289,600-12.07%
2023-08-24SaleSVP and CMO
600
0.0005%
$15.02$9,012-13.00%
2023-08-23SaleSVP and CMO
34,857
0.0271%
$15.01$523,204-13.81%
2023-08-08Saledirector
1.5M
1.1284%
$14.39$21.59M-11.69%
2023-08-08SaleSVP and CMO
2,600
0.002%
$15.05$39,130-11.69%
2023-08-08SalePresident & COO
40,000
0.0311%
$14.87$594,900-11.69%
2023-08-07SaleChief Accounting Officer
8,061
0.0062%
$14.54$117,247-10.46%
2023-06-14Saledirector
500,000
0.3927%
$12.68$6.34M+6.26%
2023-05-18Saledirector
1M
0.7525%
$10.55$10.55M+22.38%
2023-05-04SalePresident & COO
17,515
0.0137%
$10.90$190,914+22.94%

Insider Historical Profitability

9.64%
Janssen RobertSVP and CMO
49925
0.038%
$12.36420+63.59%
CANO FRANCISdirector
36905
0.0281%
$12.3623+47.76%
Novack David FPresident & COO
3187
0.0024%
$12.36122+50.89%
Hack Andrew A. F.director
915000
0.6961%
$12.3617+34.01%
ORONSKY ARNOLD Ldirector
375055
0.2853%
$12.3621+31.61%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$287.8M17.7223.19M-0.88%-$2.55M0.01
State Street$131.69M8.1110.61M+11.75%+$13.85M0.01
The Vanguard Group$116.68M7.189.4M+1.36%+$1.57M<0.01
Deep Track Capital Lp$113.45M6.989.14M+28.88%+$25.42M0.52
Federated Hermes$99.14M6.17.99M-29.7%-$41.89M0.23
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.